Professor Richard Morgan
Founder

Professor Morgan graduated in Natural Sciences from the University of Cambridge in 1990 and gained his doctorate in Biochemistry from the University of Birmingham in 1993. In the following years, he was Postdoctoral Scientist, MRC National Institute for Medical Research, London (1993-1997) and at the Hubrecht Laboratory for Developmental Biology, Utrecht, The Netherlands (1997-2000). Subsequently, he held the posts of Lecturer in Cell and Developmental Biology, St George’s, University of London (2000-2006) and Senior Lecturer in Molecular Oncology, University of Surrey (2006-2014), and then in 2014 he became Professor of Molecular Oncology at Bradford University and in February 2016 he accepted the Directorship of the prestigious Institute of Cancer Therapeutics. Prof Morgan’s group is working on the HOX and TMEM92 projects described above along with a number of other studies of new molecular targets in cancer